Drugs & Targets Boehringer Ingelheim, OSE Immunotherapeutics collaborate to advance clinical development of SIRP immuno-oncology program July 12, 2024Vol.50 No.28
Drugs & Targets Wistar, Accelerated Biosciences collaborate to develop immune cell therapies July 12, 2024Vol.50 No.28
Drugs & Targets FDA grants Fast Track designation to Syncromune Inc. for drug-device combo for solid tumors in mCRPC July 05, 2024Vol.50 No.27
Drugs & Targets EMA CHMP adopts positive opinion for Tepkinly in R/R follicular lymphoma July 05, 2024Vol.50 No.27
Drugs & Targets EMA CHMP adopts positive opinion for odronextamab for R/R follicular lymphoma or R/R DLBCL July 05, 2024Vol.50 No.27
Drugs & Targets eHealth Technologies, CancerX collaborate to accelerate cancer innovation in U.S. June 28, 2024Vol.50 No.26
Drugs & Targets Merck, Qure.ai collaborate to expand lung cancer detection via AI June 28, 2024Vol.50 No.26
Drugs & Targets FDA approves Keytruda combination for primary advanced or recurrent endometrial carcinoma June 21, 2024Vol.50 No.25
